Close Menu

Microarrays & Multiplexing

News on microarrays, multiplexing, genotyping, cytogenetics, gene expression profiling in genetics, genomics, and molecular diagnostics.

The test, a version of the company's rapid SARS-CoV-2 assay, will be designed for both point-of-care and at-home use as an over-the-counter product.

The company's revenue growth continues to be driven by its Alba reagents business, with some contribution from its SARS-CoV-2 antibody microarray.

Agilent said its qualitative assay is used for the postnatal diagnosis of copy-number alterations and copy-neutral loss of heterozygosity from DNA.

One of the tests is customized for use on Bioneer's automated ExiStation instrument, while the other is compatible with various standard PCR systems.

The RT-PCR-based test is designed for the qualitative detection of SARS-CoV-2 nucleic acid in upper and lower respiratory specimens.